Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Return on Equity (2018 - 2025)

Sutro Biopharma (STRO) has disclosed Return on Equity for 8 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 7.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, down 7.0% year-over-year, with the annual reading at 0.0% for FY2025, 2.0% up from the prior year.
  • Return on Equity hit 0.1% in Q4 2025 for Sutro Biopharma, up from 0.32% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.03% in Q4 2024 to a low of 1.29% in Q3 2023.
  • Historically, Return on Equity has averaged 0.61% across 5 years, with a median of 0.59% in 2022.
  • Biggest five-year swings in Return on Equity: tumbled -73bps in 2023 and later soared 78bps in 2024.
  • Year by year, Return on Equity stood at 0.35% in 2021, then tumbled by -51bps to 0.53% in 2022, then plummeted by -53bps to 0.82% in 2023, then surged by 96bps to 0.03% in 2024, then crashed by -222bps to 0.1% in 2025.
  • Business Quant data shows Return on Equity for STRO at 0.1% in Q4 2025, 0.32% in Q3 2025, and 0.93% in Q2 2025.